Answers are grounded in this paper and cite their sources.
This analysis shows that, of the patients included in this review, 31% relapsed after treatment. The highest risk of relapse is during the first year after discharge and this risk continues for up to 2 years. An overview was made of all factors significantly associated with a higher risk of relapse, resulting in the following four clusters: eating disorder variables, comorbidity symptoms, process treatment variables and demographic variables. Future research on relapse prevention is necessary to further unravel the mechanisms that might lead to relapse.
No takes yet. Share an insight, caveat, or question.
Berends et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: